Patent Assignment
Reel/Frame 059076/0715
Assignment of Assignor's Interest
Recorded: 2022-02-23
Pages: 9
Assignors
LOTERSZTAJN, SOPHIE
Executed: 2020-01-13
WAN, JINGHONG
Executed: 2020-01-14
PARADIS, VALERIE
Executed: 2020-01-14
LEHUEN, AGNES
Executed: 2020-01-13
HEGDE, PUSHPA
Executed: 2020-01-14
WEISS, EMMANUEL
Executed: 2020-01-13
Assignees
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
101, RUE DE TOLBIAC, PARIS, 75013, FRANCE
UNIVERSITÉ PARIS DIDEROT - PARIS 7
5, RUE THOMAS MANN, PARIS, 75013, FRANCE
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
3, RUE MICHEL ANGE, PARIS, 75016, FRANCE
UNIVERSITÉ PARIS DESCARTES
12, RUE D'ECOLE DE MÉDECINE, PARIS, 75006, FRANCE
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP)
3, AVENUE VICTORIA, PARIS, 75004, FRANCE
Covered Property
(1)
Methods and Pharmaceutical Compositions for the Treatment of Fibrosis with Agents Capable of Inhibiting the Activation of Mucosal-Associated Invariant T (Mait) Cells
Application:
16/625,381 →
Publication:
US 2021/0403573
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.